203 related articles for article (PubMed ID: 10084454)
41. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
[TBL] [Abstract][Full Text] [Related]
42. Community-acquired pneumonia.
Lynch JP; Martinez FJ
Curr Opin Pulm Med; 1998 May; 4(3):162-72. PubMed ID: 9675519
[TBL] [Abstract][Full Text] [Related]
43. The role of new therapies for severe community-acquired pneumonia.
Restrepo MI; Anzueto A
Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
[TBL] [Abstract][Full Text] [Related]
44. [Questionnaire survey of guideline implementation for community acquired pneumonia with retrospective analysis of the empiric treatment in 490 patients].
Xu ZJ; Ding K; Huang H; Sun TY; Ke HX; Tong ZH; Wei TN; Peng K; Yao B; Li FX; Liu JH; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):442-6. PubMed ID: 17673019
[TBL] [Abstract][Full Text] [Related]
45. [Community acquired pneumonia - treatment options according to the international recommendations].
Lewandowska K; Kuś J
Wiad Lek; 2016; 69(2 Pt 1):139-44. PubMed ID: 27421128
[TBL] [Abstract][Full Text] [Related]
46. Antibiotic stewardship in community-acquired pneumonia.
Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
[TBL] [Abstract][Full Text] [Related]
47. [The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].
Matsushima T;
Nihon Rinsho; 2003 Feb; 61 Suppl 2():677-81. PubMed ID: 12722300
[No Abstract] [Full Text] [Related]
48. Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American Working Group (ConsenSur).
Bantar C; Bavestrello L; Curcio D; Jasovich A; Absi R; Bagnulo H; Famiglietti A; García P; Labarca J; Mera J; Pedreira W; Sader H; Thompson L; Wey S;
J Chemother; 2002 Dec; 14 Suppl 4():1-22. PubMed ID: 12680511
[TBL] [Abstract][Full Text] [Related]
49. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
[No Abstract] [Full Text] [Related]
50. Management and prevention strategies for community-acquired pneumonia in the Gulf Corporation Council.
Memish ZA; Arabi YM; Ahmed QA; Shibl AM; Niederman MS;
J Chemother; 2007 Oct; 19 Suppl 1():33-46. PubMed ID: 18073168
[TBL] [Abstract][Full Text] [Related]
51. BTS guidelines for the management of community acquired pneumonia in adults: update 2009.
Lim WS; Baudouin SV; George RC; Hill AT; Jamieson C; Le Jeune I; Macfarlane JT; Read RC; Roberts HJ; Levy ML; Wani M; Woodhead MA;
Thorax; 2009 Oct; 64 Suppl 3():iii1-55. PubMed ID: 19783532
[No Abstract] [Full Text] [Related]
52. Antimicrobial therapy of community-acquired pneumonia.
File TM; Niederman MS
Infect Dis Clin North Am; 2004 Dec; 18(4):993-1016, xi. PubMed ID: 15555836
[TBL] [Abstract][Full Text] [Related]
53. Evidence-based medicine: empiric antibiotic therapy in community-acquired pneumonia.
Read RC
J Infect; 1999 Nov; 39(3):171-8. PubMed ID: 10714789
[TBL] [Abstract][Full Text] [Related]
54. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations.
Miyashita N; Matsushima T; Oka M; Japanese Respiratory Society
Intern Med; 2006; 45(7):419-28. PubMed ID: 16679695
[TBL] [Abstract][Full Text] [Related]
55. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
Niven DJ; Laupland KB
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
[TBL] [Abstract][Full Text] [Related]
56. Community-Acquired Pneumonia in Adults: Diagnosis and Management.
Kaysin A; Viera AJ
Am Fam Physician; 2016 Nov; 94(9):698-706. PubMed ID: 27929242
[TBL] [Abstract][Full Text] [Related]
57. Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.
Simoens S
Curr Med Res Opin; 2009 Oct; 25(10):2447-57. PubMed ID: 19678752
[TBL] [Abstract][Full Text] [Related]
58. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.
Segreti J; House HR; Siegel RE
Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674
[TBL] [Abstract][Full Text] [Related]
59. Severe community-acquired pneumonia: the need to customize empiric therapy.
Wunderink RG; Waterer GW
Chest; 2001 Oct; 120(4):1053-5. PubMed ID: 11591535
[No Abstract] [Full Text] [Related]
60. Community-acquired respiratory infections: spectrum of organisms and treatment.
McKellar PP
J Med Liban; 2000; 48(4):264-9. PubMed ID: 11214199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
